Jurnal Respirologi Indonesia
Vol 46 No 4 (2026)

A Descriptive Study on Clinical Characteristics, Recovery Rates, and Treatment Outcomes of Drug-Resistant Tuberculosis Patients Receiving the Bedaquiline-Pretomanid-Linezolid (BPaL) Regimen

Fitria Rika Aryanti (UI)



Article Info

Publish Date
02 Nov 2026

Abstract

Background: Drug-resistant tuberculosis (DR-TB) remains a serious health challenge due to prolonged treatment duration, pill burden, and declining success rates. The Bedaquiline, Pretomanid, and Linezolid (BPaL) regimen offers a promising alternative with shorter treatment duration and potentially fewer side effects. This study aims to provide clinical characteristics, recovery rate, and outcomes of BPaL regimen administration in DR-TB patients. Methods: This descriptive quantitative study was conducted at Persahabatan Hospital, involving 35 DR-TB patients treated with the BPaL regimen between 2022 and 2024. Secondary data were collected from medical records accessed via simrspersahabatan.co.id on April 17, 2024. Data included patient demographics, clinical signs and symptoms, treatment history, side effects, success rate, culture conversion, and patient’s compliance. Data analysis was conducted in three stages: reduction (filtering relevant data), presentation (using tables, graphs, and descriptive narration), and conclusion drawing (interpreting patterns and comparing with relevant literature). Statistical analysis was performed using Google Sheets. Results: The average age of patients was 43 years, with normal BMI, pre-XDR-TB status, comorbid diabetes mellitus, and a history of previous TB treatment. Common clinical symptoms included productive cough, shortness of breath, and hemoptysis. The treatment success rate reached 94.3%, with most patients achieving culture conversion within three months and demonstrating high treatment compliance. Adverse effects were mostly grade 2, including respiratory symptoms, peripheral neuropathy, nausea, and vomiting. Conclusion: This research shows that a positive clinical picture can increase the successful recovery of DR-TB patients, with a high success rate of BPaL regimen, minimal side effects, and patient compliance with treatment until completion.

Copyrights © 2026






Journal Info

Abbrev

jri

Publisher

Subject

Health Professions Medicine & Pharmacology

Description

Jurnal Respirologi Indonesia (JRI) is an online and printed scientific publication of the Indonesian Society of Respirology (ISR). The journal is published thrice-monthly within a year (January, April, July and October). The journal is focused to present original article, article review, and case ...